#lung cancer

Explore 2 articles curated under this topic

Archive DigestArchive overview for readers

HOTMolly Carlson Makes History with First-Ever Free-Floating Iceberg Dive in the ArcticHOTMelania Trump Brokers Oleshky Ceasefire: A Diplomatic Breakthrough in UkraineHOTBrazil Decides: The High-Stakes Presidential Runoff Between Lula and BolsonaroHOTA New Dawn in the Fight Against Ebola: DR Congo Launches Pivotal Vaccine TrialHOTBreakthrough in Small Cell Lung Cancer: Tarlatamab Plus Durvalumab Offers Hope with 58% Reduced Death RiskHOTReddit's r/opensource AI Ban Sparks Intense Debate on the Future of Open Source TechnologyHOTJay-Z Set to Headline Super Bowl 2027 Halftime Show: A Historic CollaborationHOTJenna Ortega Bids Farewell to Television: A Post-'Wednesday' Era DawnsHOTOpenAI Faces Wrongful Death Lawsuit Over ChatGPT Medical AdviceHOTAlphabet and Microsoft Report Q3 2026 Earnings Amid AI Boom

Editorial Team

What you'll find under #lung cancer

This topic page collects 2 articles tagged with lung cancer on AI BlogX, making it easier to scan related coverage, follow the latest reporting, and keep the story in context.

2 articlesLatest archive pageTopic archive

This topic view stays aligned with the canonical tag archive and the article cards below.

Health

Pope Leo XIV Undergoes Successful Lung Surgery and Faces Lung Cancer Diagnosis

Pope Leo XIV, leader of the Catholic Church, underwent successful lung surgery during which he was diagnosed with pulmonary adenocarcinoma. The Vatican's unprecedented transparency regarding the 71-year-old Pontiff's health highlights the critical intersection of modern medicine and global leadership.

By AI BlogX Editorial Team

Oct 14, 2026•12m

Health

Breakthrough in Lung Cancer Treatment: Ivonescimab Delivers Positive Overall Survival Results at WCLC 2026

The HARMONi-2 trial results presented at WCLC 2026 demonstrate that ivonescimab significantly improves overall survival compared to pembrolizumab in patients with PD-L1-positive advanced NSCLC. This first-in-class bispecific antibody offers a groundbreaking dual-targeting approach for immuno-oncology.

By AI BlogX Editorial Team

Sep 15, 2026•9m

Explore more

Trend-focused workflow

Stories are monitored from trending signals, then processed for accurate summaries, fact-checking, and desk oversight.

Editorial policy

LATEST

POLITICSIsrael's Political Crossroads: Netanyahu's Bloc Secures 53 Seats in Contentious October 2026 ElectionsSPORTSMilwaukee Makes History: Brewers Clinch First World Series Title in Franchise History!TECHNOLOGYSpain Erupts in Protests After Deadly High-Speed Train Crash Claims 69 LivesPOLITICSA New Dawn or Deepening Shadows? UN Political Mission Exits Somalia Amid Election TurmoilSPORTSMilwaukee Brewers Claim Historic First World Series Title in 2026TECHNOLOGYOpenAI Faces Wrongful Death Lawsuit Over ChatGPT Medical AdviceTECHNOLOGYAlphabet and Microsoft Report Q3 2026 Earnings Amid AI BoomSCIENCEA New Dawn in Microbiology: Unveiling Bernardella, Honoring Dr. Kathryn BernardPOLITICSUS Warns Gulf Allies of Potential Military Campaign Against Iran Post-MidtermsTECHNOLOGYApple Unleashes a Wave of Innovation with New iPad Mini and Teased Mac UpgradesENTERTAINMENTJay-Z Set to Headline Super Bowl 2027 Halftime Show: A Historic CollaborationHEALTHUnlocking the Secrets Within: Scientists Reveal Profound Insights into Living Cells in Human Milk